(Utkast) Kommisjonens gjennomføringsforordning (EU) …/… om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperiodene for de aktive stoffene azadiraktin, bupir imat, ditianon, fluoksastrobin, fostiazat, heksytiazoks, isoksaben, kalksvovel, pendimetalin, pirimifosmetyl, propamokarb, prosulfokarb, natrium-5-nitroguaiakolat, natrium-o-nitrofenolat, natrium-p-nitrofenolat, sulfurylfluorid, tau-fluvalinat, tebufenozid, tebufenpyrad, tritikonazol og ziram
Plantevernmidler: forlengelse av godkjenningsperioden for 21 aktive stoffer i plantevernmidler
Utkast til kommisjonsforordning godkjent av komite (representanter for medlemslandene) og publisert i EUs komitologiregister 17.11.2026
Bakgrunn
(fra kommisjonsforordningen)
(1) The active substances azadirachtin, bupirimate, dithianon, fluoxastrobin, fosthiazate, hexythiazox, isoxaben, lime sulphur, pendimethalin, pirimiphos-methyl, propamocarb, prosulfocarb, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium pnitrophenolate, sulfuryl fluoride, tau-fluvalinate, tebufenozide, tebufenpyrad, triticonazole and ziram were approved as active substances for use in plant protection products for a limited period of time and the applications for the renewal of their approvals are currently being evaluated pursuant to Article 14 of Regulation (EC) No 1107/2009.
(2) Commission Directive 2003/31/EC included pendimethalin in Annex I to Council Directive 91/414/EEC as an active substance until 31 December 2013 and Commission Implementing Regulation (EU) 2017/1114 renewed the approval of the active substance as a candidate for substitution until 31 August 2024. The approval of pendimethalin was extended two times, most recently by Commission Implementing Regulation (EU) 2024/2221 until 15 January 2027.
(3) Commission Directive 2003/81/EC included ziram in Annex I to Directive 91/414/EEC as an active substance until 31 July 2014 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of ziram was extended nine times, most recently by Commission Implementing Regulation (EU) 2025/99 until 31 January 2027.
(4) Commission Directive 2003/84/EC included fosthiazate in Annex I to Directive 91/414/EEC as an active substance until 31 December 2013 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of fosthiazate was extended nine times, most recently by Commission Implementing Regulation (EU) 2023/1757 until 31 January 2027.
(5) Commission Directive 2006/39/EC included triticonazole in Annex I to Directive 91/414/EEC as an active substance until 31 January 2017 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of triticonazole was extended eight times, most recently by Implementing Regulation (EU) 2025/99 until 31 January 2027.
(6) Commission Directive 2007/25/EC11 included propamocarb in Annex I to Directive 91/414/EEC as an active substance until 30 September 2017 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of propamocarb was extended eight times, most recently by Commission Implementing Regulation (EU) 2025/787 until 31 January 2027.
(7) Commission Directive 2007/52/EC included pirimiphos-methyl in Annex I to Directive 91/414/EEC as an active substance until 30 September 2017 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of pirimiphos-methyl was extended eight times, most recently by Implementing Regulation (EU) 2025/787 until 31 January 2027.
(8) Commission Directive 2007/76/EC included prosulfocarb in Annex I to Directive 91/414/EEC as an active substance until 31 October 2018 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of prosulfocarb was extended six times, most recently by Implementing Regulation (EU) 2023/1757 until 31 January 2027.
(9) Commission Directive 2008/44/EC included fluoxastrobin in Annex I to Directive 91/414/EEC as an active substance until 31 July 2018 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of fluoxastrobin was extended seven times, most recently by Implementing Regulation (EU) 2025/787 until 31 January 2027.
(10) Commission Directive 2009/11/EC included sodium 5-nitroguaiacolate, sodium onitrophenolate, sodium p-nitrophenolate and tebufenpyrad in Annex I to Directive 91/414/EEC as active substances until 31 October 2019 and they were subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approvals of all those active substances were extended three times, most recently by Implementing Regulation (EU) 2023/1757 until 31 January 2027.
(11) Commission Directive 2010/38/EU included sulfuryl fluoride in Annex I to Directive 91/414/EEC as an active substance until 31 October 2020 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of sulfuryl fluoride was extended two times, most recently by Implementing Regulation (EU) 2023/1757 until 31 January 2027.
(12) Commission Directive 2011/19/EU included tau-fluvalinate in Annex I to Directive 91/414/EEC as an active substance until 31 May 2021 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of tau-fluvalinate was extended three times, most recently by Commission Implementing Regulation (EU) 2024/1206 until 31 January 2027.
(13) Commission Directive 2011/25/EU included bupirimate in Annex I to Directive 91/414/EEC as an active substance until 31 May 2021 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of bupirimate was extended three times, most recently by Implementing Regulation (EU) 2024/1206 until 31 January 2027.
(14) Commission Directive 2011/32/EU included isoxaben in Annex I to Directive 91/414/EEC as an active substance until 31 May 2021 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of isoxaben was extended three times, most recently by Implementing Regulation (EU) 2024/1206 until 31 January 2027.
(15) Commission Implementing Directive 2011/41/EU included dithianon in Annex I to Directive 91/414/EEC as an active substance until 31 May 2021 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of dithianon was extended three times, most recently by Implementing Regulation (EU) 2024/1206 until 31 January 2027.
(16) Commission Implementing Directive 2011/43/EU included lime sulphur in Annex I to Directive 91/414/EEC as an active substance until 31 May 2021 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of lime sulphur was extended three times, most recently by Implementing Regulation (EU) 2024/1206 until 31 January 2027.